Submitted by David Salotti on


The CMHC Education Resource Center offers a single access point for educational resources and online courses featuring the expert content and faculty from CMHC live events. Stay current on the latest clinical research and strategies, while testing your knowledge of essential topics in cardiometabolic risk management and CVD prevention. Select from a comprehensive array of complimentary CME-CE activities in a variety of formats to meet your needs, available on-demand and on-the-go!
Featured Activity
Pulmonary arterial hypertension (PAH) is a rare, progressive form of pulmonary hypertension characterized by elevated pulmonary arterial pressure and vascular remodeling, which can lead to right-sided heart failure and death if untreated. Despite its rarity, the prevalence of PAH is increasing, with significant knowledge gaps among clinicians regarding risk assessment, treatment goals, and advancements in therapies. This webinar will discuss how managing PAH remains complex and emphasize the need for clinicians to adopt goal-directed therapy and optimize treatment strategies to improve patient outcomes.
*NEW Featured Activity*
![]() |
This recording of a session led by experts, Keith Ferdinand and Naomi Fisher from the 20th Annual CMHC meeting, focuses on understanding the prevalence and impact of resistant hypertension in high-risk individuals, identifying contributing factors for early evaluation and treatment, and exploring recent FDA-approved therapies and emerging pharmacological options. It also highlights findings from pivotal clinical trials, real-world data on renal denervation, and national guideline recommendations. Additionally, it emphasizes the importance of individualized treatment strategies to optimize blood pressure control and reduce adverse outcomes in high-risk patients.

Facebook
X
LinkedIn
Forward
